West replaces Nick McCooke, who led Solexa through its early period in developing single molecule arrays.
"On joining Solexa, I have been impressed with how far it has progressed toward practical implementation," said West. "While other companies propose stretching the microtiter plate concept to the limit with expensive microfluidic designs, Solexa has moved directly to the molecular level. This promises thousand fold higher density t
Aside from working at Applied Biosystems, West has also held senior positions as president of Princeton Instruments, president and founder of BioAutomation and marketing director for microfluidics at Microcosm Technologies. West has been working in the biotechnology industry for 22 years.
West's appointment came after Lynx Therapeutics announced that the company may be merging with Solexa for $2.5 million in loans (see GenomeWeb Aug. 13 story).